首页 > 最新文献

Cerebrovascular Diseases Extra最新文献

英文 中文
Near Complete Reversal Of Large Diffusion-Weighted Imaging Lesion After Thrombectomy: A Case Report And Literature Review. 血栓切除术后大型弥散加权成像病变近乎完全逆转:病例报告和文献综述。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-22 DOI: 10.1159/000541905
Huy Quang Dang, Trung Quoc Nguyen, Duc Nguyen Chiem, Tra Vu Son Le, Ryan Anh-Quang Nguyen, Huy Nguyen, Thang Huy Nguyen

Introduction: Diffusion-Weighted Imaging (DWI) plays a crucial role in acute ischemic stroke (AIS), as it is used to evaluate the ischemic lesions that are irreversibly damaged. The reversibility of DWI ischemic lesions has been noted in patients with AIS who undergo revascularization therapy. In addition, the occurrence of this phenomenon in large ischemic regions remains rare, particularly the near-complete reversal of large DWI lesion cases.

Case presentation: A 58-year-old male presented with a generalized tonic-clonic seizure. Emergent magnetic resonance imaging (MRI) revealed an extremely large infarction lesion in the right hemisphere with an Alberta Stroke Program Early Computed Tomographic Score (ASPECTS) value of 2 and occlusion of the terminal right internal carotid artery. The patient was immediately transferred to the Digital Subtraction Angiography (DSA) Unit for endovascular treatment with a stent retriever. After a rapid successful reperfusion with expanded treatment in cerebral infarction (eTICI) score of 3, the patient promptly recovered 24 hours after the procedure. A brain MRI was repeated after 8 days of admission, and interestingly, the DWI lesion showed significant reversal. The modified Rankin scale (mRS) at discharge was 2 and 1 at 90-day follow-up, respectively.

Conclusions: Our case shows that the reversibility of DWI ischemic lesions can occur during the acute stroke phase, even in patients with extremely large regions, if rapid and successful reperfusion is achieved. The clinical implications of this phenomenon indicate that using DWI to evaluate the infarct core should be interpreted with caution.

导言弥散加权成像(DWI)在急性缺血性卒中(AIS)中起着至关重要的作用,因为它可用于评估不可逆转损伤的缺血性病灶。在接受血管重建治疗的 AIS 患者中,DWI 缺血性病变具有可逆性。此外,在大面积缺血区域出现这种现象仍属罕见,尤其是大面积 DWI 病变近乎完全逆转的病例:一名 58 岁的男性因全身强直-阵挛发作而就诊。急诊磁共振成像(MRI)显示,患者右侧大脑半球出现超大梗死病灶,阿尔伯塔省卒中项目早期计算机断层扫描评分(ASPECTS)值为 2,右侧颈内动脉末端闭塞。患者被立即转到数字减影血管造影(DSA)室,使用支架回取器进行血管内治疗。经过快速成功的再灌注,脑梗塞扩大治疗(eTICI)评分为 3 分,患者在术后 24 小时迅速康复。入院 8 天后复查了脑部磁共振成像,有趣的是,DWI 病变出现了明显逆转。出院时的改良兰金量表(mRS)评分为2分,90天随访时的评分为1分:我们的病例表明,在急性卒中阶段,如果快速、成功地实现再灌注,即使患者的病变区域非常大,DWI缺血性病变也会发生逆转。这一现象的临床意义表明,使用 DWI 评估梗死核心应慎重。
{"title":"Near Complete Reversal Of Large Diffusion-Weighted Imaging Lesion After Thrombectomy: A Case Report And Literature Review.","authors":"Huy Quang Dang, Trung Quoc Nguyen, Duc Nguyen Chiem, Tra Vu Son Le, Ryan Anh-Quang Nguyen, Huy Nguyen, Thang Huy Nguyen","doi":"10.1159/000541905","DOIUrl":"https://doi.org/10.1159/000541905","url":null,"abstract":"<p><strong>Introduction: </strong>Diffusion-Weighted Imaging (DWI) plays a crucial role in acute ischemic stroke (AIS), as it is used to evaluate the ischemic lesions that are irreversibly damaged. The reversibility of DWI ischemic lesions has been noted in patients with AIS who undergo revascularization therapy. In addition, the occurrence of this phenomenon in large ischemic regions remains rare, particularly the near-complete reversal of large DWI lesion cases.</p><p><strong>Case presentation: </strong>A 58-year-old male presented with a generalized tonic-clonic seizure. Emergent magnetic resonance imaging (MRI) revealed an extremely large infarction lesion in the right hemisphere with an Alberta Stroke Program Early Computed Tomographic Score (ASPECTS) value of 2 and occlusion of the terminal right internal carotid artery. The patient was immediately transferred to the Digital Subtraction Angiography (DSA) Unit for endovascular treatment with a stent retriever. After a rapid successful reperfusion with expanded treatment in cerebral infarction (eTICI) score of 3, the patient promptly recovered 24 hours after the procedure. A brain MRI was repeated after 8 days of admission, and interestingly, the DWI lesion showed significant reversal. The modified Rankin scale (mRS) at discharge was 2 and 1 at 90-day follow-up, respectively.</p><p><strong>Conclusions: </strong>Our case shows that the reversibility of DWI ischemic lesions can occur during the acute stroke phase, even in patients with extremely large regions, if rapid and successful reperfusion is achieved. The clinical implications of this phenomenon indicate that using DWI to evaluate the infarct core should be interpreted with caution.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142510132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebral venous sinus thrombosis - Current updates in the Asian context. 脑静脉窦血栓--亚洲背景下的最新进展。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-15 DOI: 10.1159/000541937
Angel Miraclin T, Deepti Bal, Ivy Sebastian, Satish Shanmugasundaram, Sanjith Aaron, Jeyaraj D Pandian

Background Cerebral venous sinus thrombosis (CVT) is a life-threatening cause of stroke in Asian countries. South Asia, comprising of India, Pakistan and Bangladesh and contributed to 40% of strokes in women. Major CVT registries are from the western nations, which differs from the Asian countries with respect to epidemiology, gender biases and risk factors. This review focusses on the various aspects of relevance in evaluation and management of patients with CVT in the Asian context. Summary The incidence of CVT is higher in Asia than in Western nations. Young age, female gender, especially in pregnancy and puerperal period, and dehydration appear to be the critical risk factors. Tropical infections like malaria, scrub typhus, and flaviviral encephalitis predispose to CVT. There is a higher prevalence of inherited thrombophilia in the Asian cohorts, contributing to prothrombotic states. Anticoagulation and supportive management offer excellent outcomes. Newer anticoagulants are safe and efficacious. In medically refractory cases, endovascular treatment offers modest benefits. Decompressive hemicraniectomy, when done early, offers mortality benefits in patients with large hemorrhagic venous infarctions. Key messages CVT is an important cause of stroke with high-burden in South Asian countries. Establishment of robust registries is the need of the hour; to study the natural history, course and outcomes and to develop management algorithms tailored to the available resources.

背景 大脑静脉窦血栓形成(CVT)是亚洲国家中危及生命的脑卒中病因。南亚包括印度、巴基斯坦和孟加拉国,其中 40% 的中风患者为女性。主要的 CVT 登记来自西方国家,在流行病学、性别偏见和风险因素方面与亚洲国家有所不同。本综述将重点讨论亚洲 CVT 患者评估和管理的各个方面。摘要 亚洲的 CVT 发病率高于西方国家。年轻、女性(尤其是孕期和产褥期)和脱水似乎是关键的风险因素。疟疾、恙虫病和黄病毒性脑炎等热带传染病易导致 CVT。在亚洲人群中,遗传性血栓性疾病的发病率较高,这也是导致血栓形成的原因之一。抗凝和支持性治疗可取得良好疗效。新型抗凝剂安全有效。在药物难治性病例中,血管内治疗可带来一定的益处。对于大面积出血性静脉梗死患者,早期进行减压颅骨切除术可降低死亡率。关键信息 在南亚国家,CVT 是中风的重要病因,且负担沉重。当务之急是建立健全的登记制度;研究自然病史、病程和预后,并根据现有资源制定管理算法。
{"title":"Cerebral venous sinus thrombosis - Current updates in the Asian context.","authors":"Angel Miraclin T, Deepti Bal, Ivy Sebastian, Satish Shanmugasundaram, Sanjith Aaron, Jeyaraj D Pandian","doi":"10.1159/000541937","DOIUrl":"https://doi.org/10.1159/000541937","url":null,"abstract":"<p><p>Background Cerebral venous sinus thrombosis (CVT) is a life-threatening cause of stroke in Asian countries. South Asia, comprising of India, Pakistan and Bangladesh and contributed to 40% of strokes in women. Major CVT registries are from the western nations, which differs from the Asian countries with respect to epidemiology, gender biases and risk factors. This review focusses on the various aspects of relevance in evaluation and management of patients with CVT in the Asian context. Summary The incidence of CVT is higher in Asia than in Western nations. Young age, female gender, especially in pregnancy and puerperal period, and dehydration appear to be the critical risk factors. Tropical infections like malaria, scrub typhus, and flaviviral encephalitis predispose to CVT. There is a higher prevalence of inherited thrombophilia in the Asian cohorts, contributing to prothrombotic states. Anticoagulation and supportive management offer excellent outcomes. Newer anticoagulants are safe and efficacious. In medically refractory cases, endovascular treatment offers modest benefits. Decompressive hemicraniectomy, when done early, offers mortality benefits in patients with large hemorrhagic venous infarctions. Key messages CVT is an important cause of stroke with high-burden in South Asian countries. Establishment of robust registries is the need of the hour; to study the natural history, course and outcomes and to develop management algorithms tailored to the available resources.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142477263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stroke in Asia. 亚洲的中风。
IF 1.9 Q2 Medicine Pub Date : 2024-04-24 DOI: 10.1159/000538928
Kay-Sin Tan, J. Pandian, Liping Liu, Kazunori Toyoda, T. Leung, S. Uchiyama, Sathoshi Kuroda, N. Suwanwela, Sanjith Aaron, Hui Meng Chang, Narayanaswamy Venketasubramanian
Background There is a significant burden of stroke in Asia. Asia has the largest population in the world in 2023, estimated at 4.7 billion. Approximately 9.5-10.6 million strokes will be anticipated annually in the backdrop of a diverse group of well-developed and less developed countries with large disparities in stroke care resources. In addition, Asian countries are in varying phases of epidemiological transition. Summary In this review, we examined recent epidemiological features of ischaemic stroke and intracerebral haemorrhage in Asia with recent developments in hyperacute stroke reperfusion therapy and technical improvements in intracerebral haemorrhage. The article also discussed the spectrum of cerebrovascular diseases in Asia which include intracranial atherosclerosis, intracerebral haemorrhage, infective aetiologies of stroke, moyamoya disease, vascular dissection, radiation vasculopathy and cerebral venous thrombosis. Key Messages The review of selected literature and recent updates, call for attention to the different requirements for resources within Asia and highlights the breadth of cerebrovascular diseases still requiring further research and more effective therapies.
背景 亚洲的中风负担沉重。2023 年,亚洲将成为世界上人口最多的地区,预计人口将达到 47 亿。亚洲既有发达地区,也有欠发达地区,中风医疗资源差异巨大,预计每年将发生约 950 万至 1060 万例中风。此外,亚洲国家正处于流行病学转型的不同阶段。摘要 在这篇综述中,我们研究了亚洲缺血性卒中和脑出血的最新流行病学特征,以及超急性期卒中再灌注治疗的最新进展和脑出血的技术改进。文章还讨论了亚洲的脑血管疾病谱,包括颅内动脉粥样硬化、脑内出血、感染性中风病因、moyamoya 病、血管夹层、放射性血管病和脑静脉血栓。重要信息 通过对部分文献的回顾和最近的更新,呼吁人们关注亚洲地区对资源的不同需求,并强调了仍需进一步研究和采用更有效疗法的脑血管疾病的广泛性。
{"title":"Stroke in Asia.","authors":"Kay-Sin Tan, J. Pandian, Liping Liu, Kazunori Toyoda, T. Leung, S. Uchiyama, Sathoshi Kuroda, N. Suwanwela, Sanjith Aaron, Hui Meng Chang, Narayanaswamy Venketasubramanian","doi":"10.1159/000538928","DOIUrl":"https://doi.org/10.1159/000538928","url":null,"abstract":"Background There is a significant burden of stroke in Asia. Asia has the largest population in the world in 2023, estimated at 4.7 billion. Approximately 9.5-10.6 million strokes will be anticipated annually in the backdrop of a diverse group of well-developed and less developed countries with large disparities in stroke care resources. In addition, Asian countries are in varying phases of epidemiological transition. Summary In this review, we examined recent epidemiological features of ischaemic stroke and intracerebral haemorrhage in Asia with recent developments in hyperacute stroke reperfusion therapy and technical improvements in intracerebral haemorrhage. The article also discussed the spectrum of cerebrovascular diseases in Asia which include intracranial atherosclerosis, intracerebral haemorrhage, infective aetiologies of stroke, moyamoya disease, vascular dissection, radiation vasculopathy and cerebral venous thrombosis. Key Messages The review of selected literature and recent updates, call for attention to the different requirements for resources within Asia and highlights the breadth of cerebrovascular diseases still requiring further research and more effective therapies.","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140662140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A nomogram to predict the risk of acute ischemic stroke in patients with maintenance hemodialysis: a retrospective cohort study. 预测维持性血液透析患者急性缺血性中风风险的提名图:一项回顾性队列研究。
IF 1.9 Q2 Medicine Pub Date : 2024-04-22 DOI: 10.1159/000539015
Jingyi Tong, Tingting Ji, Nan Liu, Yibin Chen, Zongjun Li, Xuejuan Lin, Yi Xing, Qifu Li
OBJECTIVEAcute ischemic stroke (AIS) stands as a leading cause of death and disability globally. This study aimed to investigate the risk factors linked with AIS in patients undergoing maintenance hemodialysis (MHD) and to create and validate nomogram models.METHODSWe examined the medical records of 314 patients with stage 5 chronic kidney disease (CKD5) undergoing MHD, who sought neurology outpatient department consultation for suspected AIS symptoms between January 2018 and December 2023. These 314 patients were randomly divided into the training cohort (n=222) and validation cohort (n=92). The Least Absolute Shrinkage Selection Operator (LASSO) regression model was employed for optimal feature selection in the AIS risk model. Subsequently, multivariable logistic regression analysis was used to construct a predictive model incorporating the features selected through LASSO. This predictive model's performance was assessed using the C-index and the area under the receiver operating characteristic curve (AUC). Additionally, calibration and clinical utility were evaluated through calibration plots and decision curve analysis (DCA). The model's internal validation was conducted using the validation cohort. Resaults: Predictors integrated into the prediction nomogram encompassed cardiovascular disease (CVD) (Odds Ratio [OR] 7.95, 95% confidence interval [CI] 2.400-29.979), smoking (OR 5.7, 95% CI 1.661-21.955), dialysis time (OR 5.91, 95% CI 5.866-29.979), low-density lipoprotein (LDL) (OR 2.99, 95% CI 0.751-13.007), and fibrin degradation products (FDP) (OR 5.47, 95% CI 1.563-23.162). The model exhibited robust discrimination, with a C-index of 0.877 and 0.915 in the internal training and validation cohorts, respectively. The AUC for the training set was 0.857, and a similar AUC of 0.905 was achieved in the validation cohort. Decision curve analysis (DCA) demonstrated a positive net benefit within a threshold risk range of 2 to 96%.CONCLUSIONThe proposed nomogram effectively identifies MHD patients at high risk of AIS at an early stage. This model holds the potential to aid clinicians in making preventive recommendations.
目的急性缺血性卒中(AIS)是导致全球死亡和残疾的主要原因。本研究旨在调查维持性血液透析(MHD)患者中与 AIS 相关的风险因素,并创建和验证提名图模型。方法我们检查了 314 名接受 MHD 治疗的 5 期慢性肾脏病(CKD5)患者的病历,这些患者在 2018 年 1 月至 2023 年 12 月期间因疑似 AIS 症状到神经科门诊就诊。这 314 名患者被随机分为训练队列(n=222)和验证队列(n=92)。AIS 风险模型采用最小绝对收缩选择操作器(LASSO)回归模型进行最佳特征选择。随后,使用多变量逻辑回归分析构建了一个预测模型,其中包含了通过 LASSO 选择的特征。该预测模型的性能使用 C 指数和接收者工作特征曲线下面积(AUC)进行评估。此外,还通过校准图和决策曲线分析(DCA)对校准和临床实用性进行了评估。该模型的内部验证是通过验证队列进行的。默认值:纳入预测提名图的预测因子包括心血管疾病(CVD)(Odds Ratio [OR] 7.95,95% 置信区间 [CI] 2.400-29.979)、吸烟(OR 5.7,95% 置信区间 [CI] 1.661-21.955)、透析时间(OR 5.91,95% CI 5.866-29.979)、低密度脂蛋白(LDL)(OR 2.99,95% CI 0.751-13.007)和纤维蛋白降解产物(FDP)(OR 5.47,95% CI 1.563-23.162)。该模型具有很强的辨别能力,内部训练组和验证组的 C 指数分别为 0.877 和 0.915。训练集的 AUC 为 0.857,验证队列的类似 AUC 为 0.905。决策曲线分析(DCA)显示,在 2% 到 96% 的阈值风险范围内,净收益为正。该模型有望帮助临床医生提出预防建议。
{"title":"A nomogram to predict the risk of acute ischemic stroke in patients with maintenance hemodialysis: a retrospective cohort study.","authors":"Jingyi Tong, Tingting Ji, Nan Liu, Yibin Chen, Zongjun Li, Xuejuan Lin, Yi Xing, Qifu Li","doi":"10.1159/000539015","DOIUrl":"https://doi.org/10.1159/000539015","url":null,"abstract":"OBJECTIVE\u0000Acute ischemic stroke (AIS) stands as a leading cause of death and disability globally. This study aimed to investigate the risk factors linked with AIS in patients undergoing maintenance hemodialysis (MHD) and to create and validate nomogram models.\u0000\u0000\u0000METHODS\u0000We examined the medical records of 314 patients with stage 5 chronic kidney disease (CKD5) undergoing MHD, who sought neurology outpatient department consultation for suspected AIS symptoms between January 2018 and December 2023. These 314 patients were randomly divided into the training cohort (n=222) and validation cohort (n=92). The Least Absolute Shrinkage Selection Operator (LASSO) regression model was employed for optimal feature selection in the AIS risk model. Subsequently, multivariable logistic regression analysis was used to construct a predictive model incorporating the features selected through LASSO. This predictive model's performance was assessed using the C-index and the area under the receiver operating characteristic curve (AUC). Additionally, calibration and clinical utility were evaluated through calibration plots and decision curve analysis (DCA). The model's internal validation was conducted using the validation cohort. Resaults: Predictors integrated into the prediction nomogram encompassed cardiovascular disease (CVD) (Odds Ratio [OR] 7.95, 95% confidence interval [CI] 2.400-29.979), smoking (OR 5.7, 95% CI 1.661-21.955), dialysis time (OR 5.91, 95% CI 5.866-29.979), low-density lipoprotein (LDL) (OR 2.99, 95% CI 0.751-13.007), and fibrin degradation products (FDP) (OR 5.47, 95% CI 1.563-23.162). The model exhibited robust discrimination, with a C-index of 0.877 and 0.915 in the internal training and validation cohorts, respectively. The AUC for the training set was 0.857, and a similar AUC of 0.905 was achieved in the validation cohort. Decision curve analysis (DCA) demonstrated a positive net benefit within a threshold risk range of 2 to 96%.\u0000\u0000\u0000CONCLUSION\u0000The proposed nomogram effectively identifies MHD patients at high risk of AIS at an early stage. This model holds the potential to aid clinicians in making preventive recommendations.","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140675237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waveform Analysis of STA-MCA Bypass graft in Revascularization Surgery for Moyamoya Disease. 莫亚莫亚氏病血管重建手术中的 STA-MCA 旁路移植波形分析。
IF 1.9 Q2 Medicine Pub Date : 2024-03-28 DOI: 10.1159/000538548
Ryuzaburo Kochi, Atsushi Kanoke, Ryosuke Tashiro, Hiroki Uchida, Hidenori Endo

Background: Postoperative hyperperfusion syndrome (PHS) is a well-known complication following superficial temporal artery (STA)-middle cerebral artery (MCA) bypass for moyamoya disease (MMD). The early detection of postoperative radiological hyperperfusion (PRH), characterized by a transient increase in local cerebral blood flow (CBF), is crucial for the early diagnosis of PHS. This study aimed to investigate the effectiveness of waveform analysis for early PRH detection.

Methods: We reviewed 52 consecutive patients who underwent STA-MCA bypass for MMD. Patients were divided into PRH and non-PRH groups based on the postoperative/preoperative CBF ratio. We collected the intraoperative bypass graft waveform and bypass flow data using a flowmeter. The pulsatile index (PI), an indicator of peripheral vascular resistance (PVR), was calculated from bypass flow data. Next, the newly proposed index of PVR, the ratio of the time from peak to 50% decay and to 100% decay (RT50), was calculated through waveform analysis. The values were then compared between the PRH and non-PRH groups.

Results: Twenty-seven of the 52 patients met the inclusion criteria. Fourteen of these 27 patients showed PRH. The RT50, but not the PI, was significantly higher in the PRH group. Linear regression analysis revealed a significant correlation between the RT50 and PI. In the receiver operating characteristic for predicting PRH, the area under the curve of RT50 was 0.750, with a cutoff value of 0.255, a sensitivity of 0.928, and a specificity of 0.500.

Conclusions: The RT50 obtained from waveform analysis is associated with PVR and can be useful for the early detection of PRH in patients with MMD.

背景:术后高灌注综合征(PHS)是众所周知的颞浅动脉(STA)-大脑中动脉(MCA)搭桥术治疗莫亚莫亚病(MMD)的并发症。术后放射学高灌注(PRH)的特征是局部脑血流(CBF)的短暂增加,早期发现PRH对于PHS的早期诊断至关重要。本研究旨在探讨波形分析在早期检测 PRH 方面的有效性:方法:我们回顾了 52 例连续接受 STA-MCA 分流治疗 MMD 的患者。根据术后/术前 CBF 比值将患者分为 PRH 组和非 PRH 组。我们使用流量计收集了术中旁路移植波形和旁路血流数据。根据旁路血流数据计算出外周血管阻力(PVR)指标--搏动指数(PI)。接着,通过波形分析计算出新提出的 PVR 指数,即从峰值到 50%衰减和到 100% 衰减的时间之比(RT50)。然后对 PRH 组和非 PRH 组的数值进行比较:52 名患者中有 27 名符合纳入标准。结果:52 名患者中有 27 人符合纳入标准,其中 14 人表现为 PRH。PRH 组的 RT50 值明显高于非 PRH 组。线性回归分析显示,RT50 和 PI 之间存在明显的相关性。在预测 PRH 的接收器操作特征中,RT50 的曲线下面积为 0.750,临界值为 0.255,灵敏度为 0.928,特异性为 0.500:通过波形分析获得的 RT50 与 PVR 相关,可用于 MMD 患者 PRH 的早期检测。
{"title":"Waveform Analysis of STA-MCA Bypass graft in Revascularization Surgery for Moyamoya Disease.","authors":"Ryuzaburo Kochi, Atsushi Kanoke, Ryosuke Tashiro, Hiroki Uchida, Hidenori Endo","doi":"10.1159/000538548","DOIUrl":"10.1159/000538548","url":null,"abstract":"<p><strong>Background: </strong>Postoperative hyperperfusion syndrome (PHS) is a well-known complication following superficial temporal artery (STA)-middle cerebral artery (MCA) bypass for moyamoya disease (MMD). The early detection of postoperative radiological hyperperfusion (PRH), characterized by a transient increase in local cerebral blood flow (CBF), is crucial for the early diagnosis of PHS. This study aimed to investigate the effectiveness of waveform analysis for early PRH detection.</p><p><strong>Methods: </strong>We reviewed 52 consecutive patients who underwent STA-MCA bypass for MMD. Patients were divided into PRH and non-PRH groups based on the postoperative/preoperative CBF ratio. We collected the intraoperative bypass graft waveform and bypass flow data using a flowmeter. The pulsatile index (PI), an indicator of peripheral vascular resistance (PVR), was calculated from bypass flow data. Next, the newly proposed index of PVR, the ratio of the time from peak to 50% decay and to 100% decay (RT50), was calculated through waveform analysis. The values were then compared between the PRH and non-PRH groups.</p><p><strong>Results: </strong>Twenty-seven of the 52 patients met the inclusion criteria. Fourteen of these 27 patients showed PRH. The RT50, but not the PI, was significantly higher in the PRH group. Linear regression analysis revealed a significant correlation between the RT50 and PI. In the receiver operating characteristic for predicting PRH, the area under the curve of RT50 was 0.750, with a cutoff value of 0.255, a sensitivity of 0.928, and a specificity of 0.500.</p><p><strong>Conclusions: </strong>The RT50 obtained from waveform analysis is associated with PVR and can be useful for the early detection of PRH in patients with MMD.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation. 心房颤动患者卒中单元出院后坚持建议抗凝治疗的预测因素。
IF 1.9 Q2 Medicine Pub Date : 2024-02-12 DOI: 10.1159/000537781
Theresa Frank, Jens Neumann, Anne Assmann, Stefanie Schreiber, Aiden Haghikia, Maria Barleben, Michael Sailer, Michael Goertler

Introduction: Non-adherence to recommended secondary preventive anticoagulation in stroke patients with atrial fibrillation (AF) is a common phenomenon although the introduction of direct oral anticoagulants (DOACs) has simplified anticoagulation management for physicians as well as for patients.

Methods: We examined the adherence of secondary preventive anticoagulation in AF patients after re-integration in their social environment 6 to 12 weeks after stroke unit and rehabilitation clinic treatment and analyzed for predictors for adherence and non-adherence. We conducted a telephone survey in consecutive patients treated between January 2013 and December 2021 at our institutional stroke unit with an acute cerebrovascular ischemic event and we analyzed discharge letters of rehabilitation clinics of those patients not anticoagulated at follow-up. All patients had known or newly diagnosed AF and in all we had recommended secondary preventive anticoagulation.

Results: Follow-up information about anticoagulant intake could be obtained in 1348 of 1685 patients (80.0%) treated within the study period. Anticoagulation rate was 91.5% with 83.6% of patients receiving DOACs and 7.9% receiving vitamin K antagonists (VKAs). Adherence to recommended anticoagulation was associated with intake of the recommended anticoagulant already at discharge (adjusted OR, 18.357; CI, 9.637 to 34.969), recommendation of a specific DOAC and dose (in contrast to "DOAC" as drug category) (adjusted OR, 2.971; CI, 1.173 to 7.255), a lower modified Rankin Scale at discharge (per point; adjusted OR, 0.813; CI, 0.663 to 0.996), younger age (per year; adjusted odds ratio [OR], 0.951; confidence interval [CI], 0.926 to 0.976), and the absence of peripheral vascular disease (adjusted OR, 0.359; CI, 0.173 to 0.746). In patients already anticoagulated at discharge adherence was 98.5%, irrespective of a patient's age, functional deficit at discharge, and peripheral vascular disease. Avoidable obstacles for non-adherence in patients not on anticoagulants at stroke unit discharge were (1) non-implementation of recommended anticoagulation by rehabilitation physicians predominantly in patients with moderate-severe or severe stroke disability (2.1%), (2) delegation of anticoagulation start from rehabilitation physicians to general practitioners/resident radiologists (1.3%), and (3) rejection of recommended anticoagulation because of patients' severe stroke disability (0.5%). Non-avoidable obstacles were contraindications to anticoagulation (2.1%) and patients' refusal (0.7%).

Conclusions: Commencing drug administration already during stroke unit hospitalization and providing an explanation for the selection of the recommended anticoagulant in discharge letters ensures high adherence at patients' re-integration in their social environment after acute stroke treatment. If drug administration cannot be comme

导言:尽管直接口服抗凝药(DOACs)的引入简化了医生和患者的抗凝管理,但中风房颤(AF)患者不坚持推荐的二级预防性抗凝治疗是一个普遍现象:我们研究了房颤患者在卒中单元和康复诊所治疗 6 至 12 周后重新融入社会环境后的二级预防性抗凝治疗依从性,并分析了依从和不依从的预测因素。我们对 2013 年 1 月至 2021 年 12 月期间在本院卒中单元接受急性脑血管缺血性事件治疗的连续患者进行了电话调查,并对随访时未进行抗凝治疗的患者的康复诊所出院信进行了分析。所有患者都有已知或新诊断的房颤,我们都建议他们进行二级预防性抗凝治疗:在研究期间接受治疗的 1685 名患者中,有 1348 人(80.0%)获得了服用抗凝剂的随访信息。抗凝率为 91.5%,其中 83.6% 的患者服用 DOAC,7.9% 的患者服用维生素 K 拮抗剂 (VKAs)。坚持推荐的抗凝治疗与以下因素有关:出院时已摄入推荐的抗凝剂(调整 OR,18.357;CI,9.637 至 34.969);推荐特定的 DOAC 和剂量(与作为药物类别的 "DOAC "相反)(调整 OR,2.971;CI,1.173 至 7.255);修改后的兰格氏评分较低。255)、出院时修改后的兰金量表较低(每点;调整后 OR,0.813;CI,0.663 至 0.996)、年龄较小(每年;调整后几率比 [OR],0.951;置信区间 [CI],0.926 至 0.976)以及无外周血管疾病(调整后 OR,0.359;CI,0.173 至 0.746)。在出院时已接受抗凝治疗的患者中,无论患者的年龄、出院时的功能缺陷和外周血管疾病如何,坚持治疗的比例均为 98.5%。卒中单元出院时未接受抗凝治疗的患者未坚持治疗的可避免障碍是:(1)康复科医生未执行建议的抗凝治疗,主要是中重度或重度卒中残疾患者(2.1%);(2)康复科医生将抗凝治疗的起始时间委托给全科医生/放射科住院医师(1.3%);(3)因患者严重卒中残疾而拒绝接受建议的抗凝治疗(0.5%)。不可避免的障碍是抗凝禁忌症(2.1%)和患者拒绝(0.7%):结论:在卒中单元住院期间就开始用药,并在出院信中说明选择推荐的抗凝药物,可确保患者在急性卒中治疗后重新融入社会环境时高度依从。如果不能在出院前开始用药,则应由卒中医生对康复医生进行教育,并让卒中医生参与到卒中后的决策过程中,这可能会减少可避免的障碍。
{"title":"Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation.","authors":"Theresa Frank, Jens Neumann, Anne Assmann, Stefanie Schreiber, Aiden Haghikia, Maria Barleben, Michael Sailer, Michael Goertler","doi":"10.1159/000537781","DOIUrl":"10.1159/000537781","url":null,"abstract":"<p><strong>Introduction: </strong>Non-adherence to recommended secondary preventive anticoagulation in stroke patients with atrial fibrillation (AF) is a common phenomenon although the introduction of direct oral anticoagulants (DOACs) has simplified anticoagulation management for physicians as well as for patients.</p><p><strong>Methods: </strong>We examined the adherence of secondary preventive anticoagulation in AF patients after re-integration in their social environment 6 to 12 weeks after stroke unit and rehabilitation clinic treatment and analyzed for predictors for adherence and non-adherence. We conducted a telephone survey in consecutive patients treated between January 2013 and December 2021 at our institutional stroke unit with an acute cerebrovascular ischemic event and we analyzed discharge letters of rehabilitation clinics of those patients not anticoagulated at follow-up. All patients had known or newly diagnosed AF and in all we had recommended secondary preventive anticoagulation.</p><p><strong>Results: </strong>Follow-up information about anticoagulant intake could be obtained in 1348 of 1685 patients (80.0%) treated within the study period. Anticoagulation rate was 91.5% with 83.6% of patients receiving DOACs and 7.9% receiving vitamin K antagonists (VKAs). Adherence to recommended anticoagulation was associated with intake of the recommended anticoagulant already at discharge (adjusted OR, 18.357; CI, 9.637 to 34.969), recommendation of a specific DOAC and dose (in contrast to \"DOAC\" as drug category) (adjusted OR, 2.971; CI, 1.173 to 7.255), a lower modified Rankin Scale at discharge (per point; adjusted OR, 0.813; CI, 0.663 to 0.996), younger age (per year; adjusted odds ratio [OR], 0.951; confidence interval [CI], 0.926 to 0.976), and the absence of peripheral vascular disease (adjusted OR, 0.359; CI, 0.173 to 0.746). In patients already anticoagulated at discharge adherence was 98.5%, irrespective of a patient's age, functional deficit at discharge, and peripheral vascular disease. Avoidable obstacles for non-adherence in patients not on anticoagulants at stroke unit discharge were (1) non-implementation of recommended anticoagulation by rehabilitation physicians predominantly in patients with moderate-severe or severe stroke disability (2.1%), (2) delegation of anticoagulation start from rehabilitation physicians to general practitioners/resident radiologists (1.3%), and (3) rejection of recommended anticoagulation because of patients' severe stroke disability (0.5%). Non-avoidable obstacles were contraindications to anticoagulation (2.1%) and patients' refusal (0.7%).</p><p><strong>Conclusions: </strong>Commencing drug administration already during stroke unit hospitalization and providing an explanation for the selection of the recommended anticoagulant in discharge letters ensures high adherence at patients' re-integration in their social environment after acute stroke treatment. If drug administration cannot be comme","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enlarged perivascular spaces predict malignant cerebral edema after acute large hemispheric infarction. 扩大的血管周围间隙预示着急性大面积脑梗塞后的恶性脑水肿。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-02-05 DOI: 10.1159/000536592
Yaxin Wei, Qingzi Zhang, Jinhui Niu, Jian Miao, Rui Ma, Kang Huo, Shaojun Wang

Introduction: Enlarged perivascular spaces (EPVS) are considered early manifestations of impaired clearance mechanisms in the brain; however, it is unclear whether EPVS they are associated with the development of malignant cerebral edema (MCE) after large hemispheric infarction (LHI). Therefore, we investigated the predictive value of EPVS in predicting MCE in LHI.

Methods: Patients suffering from acute LHI were consecutively enrolled. EPVS were rated after the stroke with validated rating scales from magnetic resonance imagess. Patients were divided into two groups according to the occurrence of MCE. Logistic regression was used to analyze the relationship between EPVS and MCE in the basal ganglia (BG) and centrum semiovale (CS) regions. Receiver operating characteristic (ROC) curves assessed the ability of EPVS individually and with other factors in predicting MCE.

Results: We included a total of 255 patients, of whom 98 were MCE patients (58 [59.2%] males, aged 70 [range=61.75-78] years) and found that atrial fibrillation, National Institutes of Health Stroke Scale score, infarct volume, neutrophil-lymphocyte ratio, and moderate-to-severe CS-EPVS were positively associated with MCE. After adjusting for confounds, moderate-to-severe CS-EPVS remained independent risk factor of MCE (odds ratio=16.212, p<0.001). According to the ROC analysis, MCE was highly suspected when CS-EPVS > 14 (sensitivity=0.82, specificity=0.48), and the guiding value were higher when CS-EPVS combined with other MCE predictors (area under the curve=0.90, sensitivity=0.74, specificity=0.90).

Conclusion: CS-EPVS were important risk factor for MEC in patients with acute LHI and can help identify patients at risk for MCE.

导言:血管周围间隙增大(EPVS)被认为是大脑清除机制受损的早期表现;然而,EPVS是否与大面积半球脑梗死(LHI)后恶性脑水肿(MCE)的发生相关尚不清楚。因此,我们研究了 EPVS 在预测 LHI 恶性脑水肿方面的预测价值:方法:连续招募急性 LHI 患者。方法:连续招募急性 LHI 患者,在卒中后使用有效的磁共振成像评分量表对 EPVS 进行评分。根据发生 MCE 的情况将患者分为两组。采用逻辑回归分析基底节(BG)和半卵圆中心(CS)区域 EPVS 与 MCE 之间的关系。受体操作特征曲线(ROC)评估了EPVS单独和与其他因素一起预测MCE的能力:我们共纳入了 255 名患者,其中 98 人为 MCE 患者(58 [59.2%] 名男性,年龄 70 [range=61.75-78] 岁),发现心房颤动、美国国立卫生研究院卒中量表评分、梗死体积、中性粒细胞-淋巴细胞比值和中重度 CS-EPVS 与 MCE 呈正相关。调整混杂因素后,中重度CS-EPVS仍是MCE的独立危险因素(几率比=16.212,P<0.001)。根据ROC分析,当CS-EPVS>14时,高度怀疑MCE(灵敏度=0.82,特异度=0.48),当CS-EPVS与其他MCE预测因素相结合时,指导值更高(曲线下面积=0.90,灵敏度=0.74,特异度=0.90):结论:CS-EPVS是急性LHI患者发生MCE的重要危险因素,有助于识别有发生MCE风险的患者。
{"title":"Enlarged perivascular spaces predict malignant cerebral edema after acute large hemispheric infarction.","authors":"Yaxin Wei, Qingzi Zhang, Jinhui Niu, Jian Miao, Rui Ma, Kang Huo, Shaojun Wang","doi":"10.1159/000536592","DOIUrl":"10.1159/000536592","url":null,"abstract":"<p><strong>Introduction: </strong>Enlarged perivascular spaces (EPVS) are considered early manifestations of impaired clearance mechanisms in the brain; however, it is unclear whether EPVS they are associated with the development of malignant cerebral edema (MCE) after large hemispheric infarction (LHI). Therefore, we investigated the predictive value of EPVS in predicting MCE in LHI.</p><p><strong>Methods: </strong>Patients suffering from acute LHI were consecutively enrolled. EPVS were rated after the stroke with validated rating scales from magnetic resonance imagess. Patients were divided into two groups according to the occurrence of MCE. Logistic regression was used to analyze the relationship between EPVS and MCE in the basal ganglia (BG) and centrum semiovale (CS) regions. Receiver operating characteristic (ROC) curves assessed the ability of EPVS individually and with other factors in predicting MCE.</p><p><strong>Results: </strong>We included a total of 255 patients, of whom 98 were MCE patients (58 [59.2%] males, aged 70 [range=61.75-78] years) and found that atrial fibrillation, National Institutes of Health Stroke Scale score, infarct volume, neutrophil-lymphocyte ratio, and moderate-to-severe CS-EPVS were positively associated with MCE. After adjusting for confounds, moderate-to-severe CS-EPVS remained independent risk factor of MCE (odds ratio=16.212, p<0.001). According to the ROC analysis, MCE was highly suspected when CS-EPVS > 14 (sensitivity=0.82, specificity=0.48), and the guiding value were higher when CS-EPVS combined with other MCE predictors (area under the curve=0.90, sensitivity=0.74, specificity=0.90).</p><p><strong>Conclusion: </strong>CS-EPVS were important risk factor for MEC in patients with acute LHI and can help identify patients at risk for MCE.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10927297/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139693192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features and Treatment Outcomes in Patients in Their Twenties with Ischemic Moyamoya Disease. 20 多岁缺血性 moyamoya 病患者的临床特征和治疗效果。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-08-12 DOI: 10.1159/000540769
Yutaro Ono, Yosuke Akamatsu, Shizuka Araya, Ryouga Yamazaki, Shunrou Fujiwara, Kohei Chida, Masakazu Kobayashi, Takahiro Koji, Kazunori Terasaki, Kuniaki Ogasawara

Introduction: Revascularization surgery is recommended for all pediatric patients with moyamoya disease (MMD) with ischemic symptoms because the brains of such patients are still developing. By contrast, no clear guidelines for selective revascularization surgery in adult patients (30 years or more) with ischemic presentation have been established. Regarding the age of initial onset of ischemic MMD, patients in their 20s are at the bottom of the distribution and this age group may share features with both adult and pediatric patients. The present prospective study aimed to clarify the clinical features and treatment outcomes of patients in their 20s (younger patients) with ischemic MMD compared with patients aged 30-60 years (older patients).

Methods: While patients with misery perfusion in the symptomatic cerebral hemisphere on 15O-positron emission tomography underwent combined surgery including direct and indirect revascularizations in the first study period and indirect revascularization alone in the second study period, patients without misery perfusion in that hemisphere received pharmacotherapy alone through the two study periods. Cerebral angiography via arterial catheterization and neuropsychological testing were performed before and after surgery.

Results: During 12 years, 12 younger patients were included and comprised 6% of all adult patients (194 patients). The incidence of misery perfusion in the affected hemisphere was significantly higher in younger (12/12 [100%]) than in older patients (57/182 [31%]) (p < 0.0001). No difference in the incidence of cerebral hyperperfusion syndrome and postoperatively declined cognition was seen between younger (2/5 [40%] and 2/5 [40%], respectively) and older (11/36 [31%] and 15/36 [42%], respectively) cerebral hemispheres undergoing combined revascularization surgery. No difference in the incidence of postoperatively formed collateral flows feeding more than one-third of the middle cerebral artery cortical territory on angiograms and postoperatively improved cognition was seen between younger (9/10 [90%] and 6/10 [60%], respectively) and older (18/22 [83%] and 14/22 [64%], respectively) cerebral hemispheres undergoing indirect revascularization surgery alone.

Conclusion: Patients in their 20s with ischemic MMD always exhibit misery perfusion in the affected hemisphere, unlike older patients, and sometimes develop cerebral hyperperfusion syndrome after combined revascularization surgery, leading to cognitive decline, similar to older patients. Moreover, indirect revascularization surgery alone forms sufficient collateral circulation and restores cognitive function in patients in their 20s, similar to older patients.

导言:建议对所有出现缺血症状的儿童莫亚莫亚氏病(MMD)患者进行血管再通手术,因为这类患者的大脑仍在发育。相比之下,对于有缺血症状的成年患者(30 岁或以上),目前尚无明确的选择性血管再通手术指南。关于缺血性多发性硬化症的初次发病年龄,20 多岁的患者处于分布的末端,这一年龄组的患者可能与成人和儿童患者具有相同的特征。本前瞻性研究旨在明确20多岁缺血性多发性硬化症患者(年轻患者)与30-60岁患者(年长患者)相比的临床特征和治疗效果:方法:15O-正电子发射断层扫描显示有症状的大脑半球有错误灌注的患者在第一个研究阶段接受了包括直接和间接血管再通在内的联合手术,在第二个研究阶段仅接受了间接血管再通手术,而该半球无错误灌注的患者在两个研究阶段均仅接受了药物治疗。手术前后通过动脉导管进行脑血管造影并进行神经心理学测试:12年间,共有12名年轻患者被纳入研究,占所有成年患者(194人)的6%。年轻患者(12/12 [100%])患侧大脑半球灌注不良的发生率明显高于年长患者(57/182 [31%])(p <0.0001)。接受联合血管再通手术的大脑半球中,年轻患者(分别为2/5[40%]和2/5[40%])和年长患者(分别为11/36[31%]和15/36[42%])的脑高灌注综合征和术后认知能力下降的发生率没有差异。单独接受间接血管再通手术的年轻大脑半球(分别为9/10[90%]和6/10[60%])和年龄较大的大脑半球(分别为18/22[83%]和14/22[64%])在血管造影上术后形成的侧支血流供养大脑皮质中动脉区域三分之一以上的发生率和术后认知能力改善方面没有差异:结论:与老年患者不同,20 多岁的缺血性 MMD 患者总是表现为患侧大脑半球灌注不良,在联合血管再通手术后有时会出现大脑高灌注综合征,导致认知能力下降,这一点与老年患者相似。此外,单独的间接血管再通手术可形成足够的侧支循环,并恢复 20 多岁患者的认知功能,这一点与老年患者相似。
{"title":"Clinical Features and Treatment Outcomes in Patients in Their Twenties with Ischemic Moyamoya Disease.","authors":"Yutaro Ono, Yosuke Akamatsu, Shizuka Araya, Ryouga Yamazaki, Shunrou Fujiwara, Kohei Chida, Masakazu Kobayashi, Takahiro Koji, Kazunori Terasaki, Kuniaki Ogasawara","doi":"10.1159/000540769","DOIUrl":"10.1159/000540769","url":null,"abstract":"<p><strong>Introduction: </strong>Revascularization surgery is recommended for all pediatric patients with moyamoya disease (MMD) with ischemic symptoms because the brains of such patients are still developing. By contrast, no clear guidelines for selective revascularization surgery in adult patients (30 years or more) with ischemic presentation have been established. Regarding the age of initial onset of ischemic MMD, patients in their 20s are at the bottom of the distribution and this age group may share features with both adult and pediatric patients. The present prospective study aimed to clarify the clinical features and treatment outcomes of patients in their 20s (younger patients) with ischemic MMD compared with patients aged 30-60 years (older patients).</p><p><strong>Methods: </strong>While patients with misery perfusion in the symptomatic cerebral hemisphere on 15O-positron emission tomography underwent combined surgery including direct and indirect revascularizations in the first study period and indirect revascularization alone in the second study period, patients without misery perfusion in that hemisphere received pharmacotherapy alone through the two study periods. Cerebral angiography via arterial catheterization and neuropsychological testing were performed before and after surgery.</p><p><strong>Results: </strong>During 12 years, 12 younger patients were included and comprised 6% of all adult patients (194 patients). The incidence of misery perfusion in the affected hemisphere was significantly higher in younger (12/12 [100%]) than in older patients (57/182 [31%]) (p &lt; 0.0001). No difference in the incidence of cerebral hyperperfusion syndrome and postoperatively declined cognition was seen between younger (2/5 [40%] and 2/5 [40%], respectively) and older (11/36 [31%] and 15/36 [42%], respectively) cerebral hemispheres undergoing combined revascularization surgery. No difference in the incidence of postoperatively formed collateral flows feeding more than one-third of the middle cerebral artery cortical territory on angiograms and postoperatively improved cognition was seen between younger (9/10 [90%] and 6/10 [60%], respectively) and older (18/22 [83%] and 14/22 [64%], respectively) cerebral hemispheres undergoing indirect revascularization surgery alone.</p><p><strong>Conclusion: </strong>Patients in their 20s with ischemic MMD always exhibit misery perfusion in the affected hemisphere, unlike older patients, and sometimes develop cerebral hyperperfusion syndrome after combined revascularization surgery, leading to cognitive decline, similar to older patients. Moreover, indirect revascularization surgery alone forms sufficient collateral circulation and restores cognitive function in patients in their 20s, similar to older patients.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention. 坚持抗凝治疗:缩小急性中风治疗与长期二级预防之间的差距。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-08-12 DOI: 10.1159/000540805
Ian Eustace
{"title":"Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention.","authors":"Ian Eustace","doi":"10.1159/000540805","DOIUrl":"10.1159/000540805","url":null,"abstract":"","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bites and Stings: Exotic Causes of Stroke in Asia. 咬伤和蛰伤:亚洲中风的外来病因。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-09-13 DOI: 10.1159/000541381
Udaya K Ranawaka

Background: Many unusual and fascinating causes of stroke are seen in Asia. Although rarely encountered in the Western world, such cases are seen not so infrequently by neurologists, physicians, and other healthcare workers in Asian countries. This article highlights some of these intriguing causes of stroke such as snakebite, scorpion stings, and bee and wasp stings.

Summary: Snakebite is a neglected tropical disease of global importance affecting over 5 million people each year, and scorpion stings and bee and wasp stings affect over a million people worldwide every year. Strokes due to these uncommon causes predominantly affect young males in their most productive years, and many victims die or remain with residual disability with significant socioeconomic consequences to the affected families and society. Both ischaemic and haemorrhagic strokes are seen, with ischaemic strokes being more common. Many unanswered questions remain regarding the pathophysiological mechanisms, clinical spectrum, and the natural history of stroke due to these causes. Antivenom is effective in snake envenoming, antivenom and prazosin are effective in scorpion envenoming, and treatment of anaphylaxis and allergy is recommended in systemic reactions due to bee or wasp stings. However, there are no treatment guidelines or expert recommendations to guide the management of stroke in these patients, and there are no data on the safety and efficacy of stroke-specific treatments such as antiplatelet therapy, thrombolysis or endovascular treatment.

Key messages: More research is clearly needed to unravel the complexities related to stroke following snakebite, scorpion envenoming, and bee and wasp stings, and to guide the development of optimal stroke treatment strategies in these unusual situations. Awareness of these exotic stroke aetiologies is important in early recognition and appropriate management of patients presenting with stroke symptoms in Asian countries, and in global travellers from the region. International collaborations would go a long way in improving our understanding of these rare but fascinating causes of stroke.

背景:亚洲有许多不寻常的、令人着迷的中风病因。虽然在西方世界很少遇到此类病例,但亚洲国家的神经科医生、内科医生和其他医护人员并不鲜见。摘要:蛇咬伤是一种被忽视的全球性热带疾病,每年影响 500 多万人,蝎子蜇伤、蜜蜂和黄蜂蜇伤每年影响全世界 100 多万人。这些罕见病因导致的脑卒中主要影响正值壮年的年轻男性,许多患者死亡或留下后遗症,给患者家庭和社会带来严重的社会经济后果。缺血性和出血性脑卒中均有发生,其中缺血性脑卒中更为常见。关于这些原因导致的中风的病理生理机制、临床表现和自然病史仍有许多未解之谜。抗蛇毒血清对蛇咬伤有效,抗蛇毒血清和哌唑嗪对蝎子咬伤有效,建议对蜜蜂或黄蜂蛰伤引起的全身反应进行过敏性休克和过敏治疗。然而,目前还没有治疗指南或专家建议来指导这些患者的中风治疗,也没有关于抗血小板治疗、溶栓或血管内治疗等中风特异性治疗的安全性和有效性的数据:关键信息:显然需要开展更多研究,以揭示蛇咬伤、蝎子咬伤、蜂蜇伤和黄蜂蜇伤后中风的复杂性,并指导制定这些异常情况下的最佳中风治疗策略。对这些异国卒中病因的认识对于早期识别和适当处理亚洲国家出现卒中症状的患者以及来自该地区的全球旅行者非常重要。国际合作将极大地提高我们对这些罕见但迷人的中风病因的认识。
{"title":"Bites and Stings: Exotic Causes of Stroke in Asia.","authors":"Udaya K Ranawaka","doi":"10.1159/000541381","DOIUrl":"10.1159/000541381","url":null,"abstract":"<p><strong>Background: </strong>Many unusual and fascinating causes of stroke are seen in Asia. Although rarely encountered in the Western world, such cases are seen not so infrequently by neurologists, physicians, and other healthcare workers in Asian countries. This article highlights some of these intriguing causes of stroke such as snakebite, scorpion stings, and bee and wasp stings.</p><p><strong>Summary: </strong>Snakebite is a neglected tropical disease of global importance affecting over 5 million people each year, and scorpion stings and bee and wasp stings affect over a million people worldwide every year. Strokes due to these uncommon causes predominantly affect young males in their most productive years, and many victims die or remain with residual disability with significant socioeconomic consequences to the affected families and society. Both ischaemic and haemorrhagic strokes are seen, with ischaemic strokes being more common. Many unanswered questions remain regarding the pathophysiological mechanisms, clinical spectrum, and the natural history of stroke due to these causes. Antivenom is effective in snake envenoming, antivenom and prazosin are effective in scorpion envenoming, and treatment of anaphylaxis and allergy is recommended in systemic reactions due to bee or wasp stings. However, there are no treatment guidelines or expert recommendations to guide the management of stroke in these patients, and there are no data on the safety and efficacy of stroke-specific treatments such as antiplatelet therapy, thrombolysis or endovascular treatment.</p><p><strong>Key messages: </strong>More research is clearly needed to unravel the complexities related to stroke following snakebite, scorpion envenoming, and bee and wasp stings, and to guide the development of optimal stroke treatment strategies in these unusual situations. Awareness of these exotic stroke aetiologies is important in early recognition and appropriate management of patients presenting with stroke symptoms in Asian countries, and in global travellers from the region. International collaborations would go a long way in improving our understanding of these rare but fascinating causes of stroke.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142298192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cerebrovascular Diseases Extra
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1